APP |
amyloid-β precursor protein |
APLP2 |
amyloid-β precursor-like protein 2 |
BBB |
blood–brain barrier |
CAF |
cancer-associated fibroblasts |
CM |
conditioned media |
CTSD |
cathepsin D |
CTSZ |
cathepsin Z |
ECM |
extracellular matrix |
EFEMP1/FBLN3 |
fibulin 3 |
EMT |
epithelial–mesenchymal transition |
ER |
estrogen receptor |
EV |
extracellular vesicle |
FBLN1 |
fibulin 1 |
FN |
fibronectin |
FST |
follistatin |
GDF15 |
growth differentiation factor 15 |
IGFBP |
insulin-like growth factor-binding protein |
IRE1 |
inositol-requiring enzyme 1 alpha |
LCN2 |
lipocalin 2 |
LDL |
low-density lipoprotein |
LEC |
lymphatic endothelial cells |
LPA |
lipoprotein A |
MEC |
microvascular endothelial cells |
MIC-1 |
macrophage inhibitory cytokine-1 |
MMP |
matrix metalloproteinase |
MSC |
mesenchymal stromal cell |
MTA |
microtubule-targeting agents |
OGF |
opioid growth factor |
PAI1 |
plasminogen activator inhibitor 1 |
PENK |
proenkephalin |
PLAT |
tissue plasminogen activator |
PLG |
plasminogen |
PR |
progesterone receptor |
SASP |
senescence-associated secretory phenotype |
SERPINE1 |
serine peptidase inhibitor E1 |
SNPs |
single-nucleotide polymorphisms |
STX |
sialyl transferase X |
suPAR/PLAUR |
soluble form of the urokinase receptor |
TF |
tissue factor |
THBS1 |
thrombospondin |
TIMP |
tissue inhibitor of metalloproteinases |
TIS |
therapeutic-induced senescent |
TME |
tumor microenvironment |
TNBC |
triple-negative breast cancer |
TSPAN11 |
tetraspanin 11 |
uPA/PLAU |
urokinase plasminogen activator |
uPAR |
urokinase plasminogen activator receptor |
VEGF |
vascular endothelial growth factor |